![Targeted Transformation of Diabetes Care in India Targeted Transformation of Diabetes Care in India](https://cdn.magzter.com/Bio Spectrum/1730124562/articles/xum-DX1qJ1730195092208/TARGETED-TRANSFORMATION-OF-DIABETES-CARE-IN-INDIA.jpg)
The Indian Council of Medical Research– India Diabetes (ICMR-INDIAB) study published in 2023 reported that the overall weighted prevalence of diabetes in India was 11·4 per cent, accounting for 101 million people. The study findings also reported an alarming increase in non-communicable diseases (NCDs) such as prediabetes, hypertension, and obesity. Hence, there is a rising need to holistically manage the rising diabetes prevalence by improving awareness, diet, lifestyle, screening, treatment and monitoring practices in India.
Public and Private Campaigns for Improving Awareness
A study of the National Family Health Survey of India (NFHS), 2019–2021 reported that diabetes awareness varied from 14.4 per cent to 54.4 per cent. Not surprisingly, the less educated and poorer sections of the society had lower diabetes awareness. Thus, considering the rising prevalence of the disease, there is a need to improve diabetes awareness in India. Several public and private initiatives are looking to address this concern.
However, it is important to ensure that the awareness campaigns have wider outreach.
For instance, mDiabetes, launched in collaboration with the Ministry of Health and Family Welfare, India and the World Health Organization (WHO) aims to provide basic diabetes information to users who dial a missed call to a number. This is likely to ensure a wide outreach as even rural Indian sectors have good mobile connectivity in India. In 2021, the Research Society for the Study of Diabetes in India (RSSDI) launched the Defeat Diabetes Campaign to reach out to over 100 million people in 100 days to ‘test, track and treat’ diabetes. The campaign was successful and managed to screen over 106 million people in over 10,000 locations in India. There is a need to continue such targeted campaigns with well-defined outcomes and timelines.
Diese Geschichte stammt aus der BioSpectrum India Nov 2024-Ausgabe von Bio Spectrum.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der BioSpectrum India Nov 2024-Ausgabe von Bio Spectrum.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
![Amit Agrawal steps in as new Pharmaceuticals Secretary Amit Agrawal steps in as new Pharmaceuticals Secretary](https://reseuro.magzter.com/100x125/articles/118/1976891/OPdXyI_4O1738140374716/AMIT-AGRAWAL-STEPS-IN-AS-NEW-PHARMACEUTICALS-SECRETARY.jpg)
Amit Agrawal steps in as new Pharmaceuticals Secretary
Amit Agrawal, the Chief Executive Officer (CEO) of the Unique Identification Authority of India (UIDAI), has been appointed as the new Secretary of the Department of Pharmaceuticals, Government of India.
![IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes](https://reseuro.magzter.com/100x125/articles/118/1976891/YgCNMGiFL1738140341452/IITB-JOINS-HANDS-WITH-TOHOKU-UNIVERSITY-TO-OFFER-MTECH-PHD-DUAL-DEGREE-PROGRAMMES.jpg)
IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes
The Indian Institute of Technology, Bombay (IIT-B) has entered into a Memorandum of Understanding (MoU) with Japan's Tohoku University to launch the IIT Bombay-Tohoku University Joint Academic & Research Programme.
![Innovative injectable hydrogel to offer targeted breast cancer therapy Innovative injectable hydrogel to offer targeted breast cancer therapy](https://reseuro.magzter.com/100x125/articles/118/1976891/OGh7lG0cD1738140707089/INNOVATIVE-INJECTABLE-HYDROGEL-TO-OFFER-TARGETED-BREAST-CANCER-THERAPY.jpg)
Innovative injectable hydrogel to offer targeted breast cancer therapy
In a multi-institutional research led by researchers from Indian Institute of Technology Guwahati (IIT-G) and Bose Institute Kolkata, an advanced injectable hydrogel has been developed for localised cancer treatment.
![Bio-Techne, Waters ink co-marketing agreement for biotherapeutic characterisation Bio-Techne, Waters ink co-marketing agreement for biotherapeutic characterisation](https://reseuro.magzter.com/100x125/articles/118/1976891/XTRAwPe-o1738141003254/BIOTECHNE-WATERS-INK-COMARKETING-AGREEMENT-FOR-BIOTHERAPEUTIC-CHARACTERISATION.jpg)
Bio-Techne, Waters ink co-marketing agreement for biotherapeutic characterisation
American life sciences company Bio-Techne Corporation, a leader in automated platforms for biotherapeutic characterisation, has announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterisation and development processes.
![Nano-formulation of darkness hormone to serve as therapeutic solution for Parkinson's disease Nano-formulation of darkness hormone to serve as therapeutic solution for Parkinson's disease](https://reseuro.magzter.com/100x125/articles/118/1976891/eU-A9tixm1738140752033/NANOFORMULATION-OF-DARKNESS-HORMONE-TO-SERVE-AS-THERAPEUTIC-SOLUTION-FOR-PARKINSONS-DISEASE.jpg)
Nano-formulation of darkness hormone to serve as therapeutic solution for Parkinson's disease
Scientists from Institute of Nano Science and Technology (INST) Mohali have proved that nano-formulation of Melatonin, the hormone produced by the brain in response to darkness, showed improved antioxidative and neuroprotective properties and could be a potential therapeutic solution for Parkinson's disease (PD).
!["Govt should facilitate low-interest loans or VC funding specifically for biopharma startups & small enterprises" "Govt should facilitate low-interest loans or VC funding specifically for biopharma startups & small enterprises"](https://reseuro.magzter.com/100x125/articles/118/1976891/v5fr83cVf1738138866738/GOVT-SHOULD-FACILITATE-LOWINTEREST-LOANS-OR-VC-FUNDING-SPECIFICALLY-FOR-BIOPHARMA-STARTUPS-SMALL-ENTERPRISES.jpg)
"Govt should facilitate low-interest loans or VC funding specifically for biopharma startups & small enterprises"
\"In a recent development, Nagpur-based biotech company GeNext Genomics (GNG) has joined -hands with Merck Life Science to support the Indian biotech system, particularly in the area of biomanufacturing, which is garnering more attention after the approval of the BioE3 policy.Supriya Kashikar, Founder & Chief Executive Officer, GeNext Genomics shares her views with BioSpectrum on the growth of biomanufacturing sector in India, and how the company plans to play a relevant role in this aspect.
![Redcliffe Labs reinforces strategic leadership as Aditya Kandoi steps into CEO role, Dheeraj Jain as Chairman Redcliffe Labs reinforces strategic leadership as Aditya Kandoi steps into CEO role, Dheeraj Jain as Chairman](https://reseuro.magzter.com/100x125/articles/118/1976891/d8BsnExa21738140587074/REDCLIFFE-LABS-REINFORCES-STRATEGIC-LEADERSHIP-AS-ADITYA-KANDOI-STEPS-INTO-CEO-ROLE-DHEERAJ-JAIN-AS-CHAIRMAN.jpg)
Redcliffe Labs reinforces strategic leadership as Aditya Kandoi steps into CEO role, Dheeraj Jain as Chairman
Redcliffe Labs, a purpose-driven pan-India omnichannel diagnostics service provider, has announced a strategic leadership transition.
![Zyla Health on-boards Rohit Boda as Advisor Zyla Health on-boards Rohit Boda as Advisor](https://reseuro.magzter.com/100x125/articles/118/1976891/bF1N2OBj-1738140454051/ZYLA-HEALTH-ONBOARDS-ROHIT-BODA-AS-ADVISOR.jpg)
Zyla Health on-boards Rohit Boda as Advisor
Gurugram-based Zyla Health, a care management platform, has announced the onboarding of renowned industry leader, Rohit Boda, to the Board of Advisors.
![Claypond Capital appoints Shravan Subramanyam to lead medtech platform Claypond Capital appoints Shravan Subramanyam to lead medtech platform](https://reseuro.magzter.com/100x125/articles/118/1976891/nkoTafYCf1738140636266/CLAYPOND-CAPITAL-APPOINTS-SHRAVAN-SUBRAMANYAM-TO-LEAD-MEDTECH-PLATFORM.jpg)
Claypond Capital appoints Shravan Subramanyam to lead medtech platform
Claypond Capital, the family investment office of Dr Ranjan Pai, has announced the appointment of Dr Shravan Subramanyam as the head of its medical technology platform.
![How AI Innovations at GCCs Solidifying India's Position in Global Life Sciences Industry How AI Innovations at GCCs Solidifying India's Position in Global Life Sciences Industry](https://reseuro.magzter.com/100x125/articles/118/1976891/PDEBaWlDZ1738140172078/HOW-AI-INNOVATIONS-AT-GCCS-SOLIDIFYING-INDIAS-POSITION-IN-GLOBAL-LIFE-SCIENCES-INDUSTRY.jpg)
How AI Innovations at GCCs Solidifying India's Position in Global Life Sciences Industry
India's life sciences sector is undergoing a major transformation, led by the expansion of Global Capability Centres GCCs). These centres, which serve as strategic hubs for multinational companies in pharmaceuticals, biotechnology, and healthcare, are strengthening India's role in the global life sciences landscape. Currently, there are over 95 life sciences GCCs in India, employing approximately 280,000 professionals. By 2030, this number is projected to reach 160 GCCs and around 420,000 employees. Advancements in artificial intelligence AI) are central to this transformation, driving innovation across drug discovery and clinical research. India's life sciences GCCs have evolved from operational support centres to world-class R&D engines, leveraging India’s robust talent pool, advanced technology adoption, and cost advantages. These GCCs are driving the future of Al-powered drug discovery and clinical research. Let’s explore further.